Fabio Malavasi

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyNeurology and neuromuscular diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 17, 2022
CD38 as a multifaceted immunotherapeutic target in CLL.

Aneel Paulus, Fabio Malavasi, Asher Chanan-Khan

|Apr 30, 2021
The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma.

Danilo Marimpietri, Irma Airoldi, Angelo Corso Faini

|May 25, 2019
Novel targets for the treatment of relapsing multiple myeloma.

Nicola Giuliani, Fabrizio Accardi, Valentina Marchica

|May 10, 2019
Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells.

Fabio Morandi, Danilo Marimpietri, Alberto L Horenstein

|Apr 04, 2019
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.

Alak Manna, Sonikpreet Aulakh, Prachi Jani

|Mar 09, 2019
Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy.

Fabio Malavasi, Angelo Corso Faini

Pageof 2

Frequent Collaborators

3 joint publications

Fabio Morandi

2 joint publications

Alberto L Horenstein

2 joint publications

Angelo Corso Faini

2 joint publications

Danilo Marimpietri